NASDAQ · ATEC
Healthcare · Medical - Devices
$10.66
Down-$0.04 (-0.36%)
Updated Sep 16, 2026, 2:09 PM
SID Score
5.8/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 20 trading sessions · Daily adjusted prices
ATEC closed at $10.66 after 20 trading sessions, up 11.86% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $10.80 | $10.94 | $10.61 | $10.66 | 2.87M |
| Sep 14, 2026 | $10.49 | $11.03 | $10.3901 | $10.86 | 4.18M |
| Sep 11, 2026 | $9.55 | $10.60 | $9.34 | $10.58 | 6.46M |
| Sep 10, 2026 | $8.77 | $8.92 | $8.60 | $8.84 | 2.38M |
| Sep 9, 2026 | $9.23 | $9.435 | $8.842 | $8.985 | 3.05M |
| Sep 8, 2026 | $9.55 | $9.55 | $9.035 | $9.19 | 1.76M |
| Sep 4, 2026 | $9.22 | $9.51 | $9.08 | $9.45 | 1.58M |
| Sep 3, 2026 | $9.33 | $9.455 | $9.05 | $9.33 | 1.86M |
| Sep 2, 2026 | $9.24 | $9.475 | $9.08 | $9.19 | 1.44M |
| Sep 1, 2026 | $9.46 | $9.57 | $9.15 | $9.21 | 1.05M |
| Aug 31, 2026 | $9.32 | $9.45 | $9.25 | $9.37 | 1.38M |
| Aug 28, 2026 | $9.55 | $9.65 | $9.40 | $9.44 | 1.21M |
| Aug 27, 2026 | $9.36 | $9.685 | $9.28 | $9.57 | 1.56M |
| Aug 26, 2026 | $9.37 | $9.49 | $9.20 | $9.42 | 1.42M |
| Aug 25, 2026 | $9.22 | $9.4715 | $9.08 | $9.33 | 1.58M |
| Aug 24, 2026 | $9.49 | $9.615 | $9.22 | $9.24 | 1.72M |
| Aug 21, 2026 | $9.26 | $9.505 | $9.11 | $9.48 | 1.45M |
| Aug 20, 2026 | $9.70 | $9.71 | $9.22 | $9.29 | 1.51M |
| Aug 19, 2026 | $9.53 | $10.00 | $9.50 | $9.75 | 1.54M |
| Aug 18, 2026 | $9.55 | $9.77 | $9.495 | $9.53 | 1.43M |
The latest Smart Investors Daily articles mentioning ATEC.
ATEC research
Company profile and research snapshot.
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 5, 2026 | UBS | Buy | — |
| Aug 5, 2026 | TD Cowen | Buy | — |
| Aug 5, 2026 | BMO Capital | Outperform | — |
| Jul 28, 2026 | UBS | Buy | — |
| Jul 23, 2026 | Stephens & Co. | Overweight | — |
No generated briefing is available yet.
Yahoo · Jan 30, 2026
Alphatec Holdings Inc. (NASDAQ:ATEC) is one of the best high short interest stocks with biggest upside potential. On January 27, TD Cowen lowered its price target for Alphatec to $20 from $27 while maintaining a Buy rating following a transfer of coverage. The firm suggested that the current market expectations do not fully appreciate the […]
SeekingAlpha · Jan 25, 2026
SeekingAlpha · Jan 14, 2026
Alphatec Holdings, Inc. (ATEC) 44th Annual J.P.
SeekingAlpha · Jan 13, 2026
Alphatec Holdings, Inc. is rated Hold, continues to deliver strong top-line growth and operational leverage. Learn more about ATEC stock here.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning ATEC.
